+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges, Dipsticks & Kits), Type (Blood & Serum Creatinine Tests, Urine Tests), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5591985
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Albumin & Creatinine Tests Market size was estimated at USD 1.47 billion in 2023, USD 1.66 billion in 2024, and is expected to grow at a CAGR of 13.23% to reach USD 3.52 billion by 2030.

The albumin & creatinine tests market constitutes diagnostic devices, reagents, and services used to measure albumin and creatinine levels in blood or urine samples. These tests are crucial in evaluating kidney function, detecting chronic kidney disease (CKD), diagnosing diabetic nephropathy, and monitoring treatment responses for various renal conditions. The rising prevalence of diabetes mellitus and hypertension, increased awareness regarding preventive healthcare measures and early diagnosis, advancements in biotechnology and biochemical analysis techniques improving test accuracy, and faster results drive market expansion. Additionally, emerging economies with large populations requiring accessible testing options present potential opportunities as governments invest more resources into healthcare infrastructure development. Despite the numerous growth avenues within this sector, certain limitations, including consistency in testing procedures, may lead to inaccuracies in test results hindering clinical decision-making processes concerning patient management. Furthermore, reimbursement issues related to medical insurance policies across countries limit patients' access to advanced testing technologies. Innovative research and development initiatives within the albumin & creatinine tests market are anticipated to generate new opportunities for business growth.

Regional Insights

The Americas region represents a mature landscape for the market, with established medical infrastructures and stringent regulations governing manufacturers and providers. Manufacturers and providers operating in the U.S., and Canada, face strict regulatory guidelines from agencies such as FDA and Health Canada to commercialize the products in the market. In the European Union, countries such as Germany, France, and Italy, along with the UK, have seen increasing demand for albumin & creatinine tests due to rising awareness about kidney diseases coupled with growth in healthcare infrastructure which is driving the market growth in the region. In the APAC region, China, Japan, and India are experiencing rapid economic growth accompanied by improving healthcare facilities that drive demand for better diagnostic tools. The rising prevalence of chronic kidney diseases (CKD), diabetes, and hypertension, as well as increased awareness about early disease detection and monitoring, has significantly boosted the demand for the albumin & creatinine tests market in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Albumin & Creatinine Tests Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Albumin & Creatinine Tests Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Albumin & Creatinine Tests Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Anamol Laboratories Pvt. Ltd., Arbor Assays Inc., ARKRAY, Inc., BTNX Inc., CompareNetworks, Inc., Danaher Corporation, Eagle Biosciences, Inc., F. Hoffmann-La Roche AG, J. Mitra & Co. Pvt. Ltd., Laboratory Corporation of America Holdings, Merck KGaA, Ortho Clinical Diagnostics, Practo Technologies Private Limited, PromoCell GmbH, Randox Laboratories Ltd., Siemens AG, Sysmex Europe SE, Thermo Fisher Scientific Inc., and UJIFILM Wako Pure Chemical Corporation.

Market Segmentation & Coverage

This research report categorizes the Albumin & Creatinine Tests Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Analyzers
    • Cartridges
      • POC Analyzer Cartridges
      • Table-top Analyzer Cartridges
    • Dipsticks & Kits
    • Reagents
  • Type
    • Blood & Serum Creatinine Tests
    • Urine Tests
      • Glycated Albumin Tests
      • Urine Albumin Tests
      • Urine Creatinine Tests
  • End User
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Research Laboratories & Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Albumin & Creatinine Tests Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Albumin & Creatinine Tests Market?
  3. What are the technology trends and regulatory frameworks in the Albumin & Creatinine Tests Market?
  4. What is the market share of the leading vendors in the Albumin & Creatinine Tests Market?
  5. Which modes and strategic moves are suitable for entering the Albumin & Creatinine Tests Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Albumin & Creatinine Tests Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of chronic kidney disorders
5.1.1.2. Rising adoption of point-of-care (POC) diagnostics
5.1.1.3. Growing cases of urinary tract infections
5.1.2. Restraints
5.1.2.1. Problems with spot urine sampling and testing
5.1.3. Opportunities
5.1.3.1. Emergence of automated systems for overall urine analysis
5.1.3.2. Introduction of home testing kit coupled with surge in number of pathology laboratory
5.1.4. Challenges
5.1.4.1. Concern with the accuracy and limited infrastructure in rural areas
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Albumin & Creatinine Tests Market, by Product
6.1. Introduction
6.2. Analyzers
6.3. Cartridges
6.4.1. POC Analyzer Cartridges
6.4.2. Table-top Analyzer Cartridges
6.4. Dipsticks & Kits
6.5. Reagents
7. Albumin & Creatinine Tests Market, by Type
7.1. Introduction
7.2. Blood & Serum Creatinine Tests
7.3. Urine Tests
7.4.1. Glycated Albumin Tests
7.4.2. Urine Albumin Tests
7.4.3. Urine Creatinine Tests
8. Albumin & Creatinine Tests Market, by End User
8.1. Introduction
8.2. Diagnostic Laboratories
8.3. Hospitals & Clinics
8.4. Research Laboratories & Institutes
9. Americas Albumin & Creatinine Tests Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Albumin & Creatinine Tests Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Albumin & Creatinine Tests Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Agreement, Collaboration, & Partnership
12.3.1.1. Healthy.io Announces Collaboration with Boehringer Ingelheim to Increase Access to Testing for Kidney Disease
12.3.2. New Product Launch & Enhancement
12.3.2.1. American Regent Launches Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)
12.3.3. Investment & Funding
12.3.3.1. Healthy.io Secures USD 50 Million in Series D Funding
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Abcam PLC
13.1.3. Anamol Laboratories Pvt. Ltd.
13.1.4. Arbor Assays Inc.
13.1.5. ARKRAY, Inc.
13.1.6. BTNX Inc.
13.1.7. CompareNetworks, Inc.
13.1.8. Danaher Corporation
13.1.9. Eagle Biosciences, Inc.
13.1.10. F. Hoffmann-La Roche AG
13.1.11. J. Mitra & Co. Pvt. Ltd.
13.1.12. Laboratory Corporation of America Holdings
13.1.13. Merck KGaA
13.1.14. Ortho Clinical Diagnostics
13.1.15. Practo Technologies Private Limited
13.1.16. PromoCell GmbH
13.1.17. Randox Laboratories Ltd.
13.1.18. Siemens AG
13.1.19. Sysmex Europe SE
13.1.20. Thermo Fisher Scientific Inc.
13.1.21. UJIFILM Wako Pure Chemical Corporation
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. ALBUMIN & CREATININE TESTS MARKET RESEARCH PROCESS
FIGURE 2. ALBUMIN & CREATININE TESTS MARKET SIZE, 2023 VS 2030
FIGURE 3. ALBUMIN & CREATININE TESTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ALBUMIN & CREATININE TESTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ALBUMIN & CREATININE TESTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ALBUMIN & CREATININE TESTS MARKET DYNAMICS
FIGURE 7. ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ALBUMIN & CREATININE TESTS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ALBUMIN & CREATININE TESTS MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • Abbott Laboratories
  • Abcam PLC
  • Anamol Laboratories Pvt. Ltd.
  • Arbor Assays Inc.
  • ARKRAY, Inc.
  • BTNX Inc.
  • CompareNetworks, Inc.
  • Danaher Corporation
  • Eagle Biosciences, Inc.
  • F. Hoffmann-La Roche AG
  • J. Mitra & Co. Pvt. Ltd.
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Ortho Clinical Diagnostics
  • Practo Technologies Private Limited
  • PromoCell GmbH
  • Randox Laboratories Ltd.
  • Siemens AG
  • Sysmex Europe SE
  • Thermo Fisher Scientific Inc.
  • UJIFILM Wako Pure Chemical Corporation

Methodology

Loading
LOADING...

Table Information